Genmab — Januar 2015
-
Interessant debat i dag om succes eller ikke for Genmab... jeg har været i branchen i mere end 20 år og tro mig alt det som så HELT sikkert ud fejlede på målstregen... så intet er sikkert før approvel..og derefter kan det vise sig at stoffet stadigvæk ikke performer som forudsagt.. og jeg tror stadigvæk meget på DARA.. ved Jansen har bestilt 16 batche DARA hos en CMO start 3q så tror de er ved at bygge lager op...
-
Golddigger
-
Kan du ikke smide din ?
så skriver jeg -
Er gjort filipa
-
AH2005 det har vi diskuteret hele formiddagen
-
Der bliver fest i gaderne i år:
-
Dr. Orlowski: I would love to. We’re very hopeful that sometime this year in 2015, probably towards the second half of the year, we may get two monoclonal antibodies approved
-
One of them is elotuzumab, which recognizes a protein on the surface of myeloma cells called SLAMF7, and the second is daratumumab, which is an antibody that recognizes a different protein called CD38.
-
Om Dara-len-dex ph 3: The exciting thing about that trial is because of all the excitement around daratumumab, it’s actually accruing more rapidly than was anticipated. We’re thinking that we will reach the needed enrollment either in March or April
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind